Literature DB >> 17525482

Familial pheochromocytomas and paragangliomas: stories from the sign-out room.

Aurel Perren1, Paul Komminoth.   

Abstract

In this overview we present five patients with apparently sporadic pheochromocytomas or paragangliomas which turned out to be associated with an inheritable familial disease. For each patient a family history together with clinical, morphological, as well as molecular data are reported. The identified syndromes include multiple endocrine neoplasia type 2 (MEN2), von Hippel-Lindau syndrome (VHL), neurofibromatosis type 1 (NF1), and familial pheochromocytoma/paraganglioma syndrome (SDHx). A brief summary of phenotypes, the genes involved, and typical mutations in these syndromes is provided.

Entities:  

Mesh:

Year:  2006        PMID: 17525482     DOI: 10.1007/s12022-006-0005-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  15 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.

Authors:  Noriko Kimura; Toshiya Watanabe; Masayuki Fukase; Atsushi Wakita; Takao Noshiro; Itaru Kimura
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

3.  Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.

Authors:  Hilde Dannenberg; Francien H van Nederveen; Mustaffa Abbou; Albert A Verhofstad; Paul Komminoth; Ronald R de Krijger; Winand N M Dinjens
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

4.  Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.

Authors:  Francesca Schiavi; Carsten C Boedeker; Birke Bausch; Mariola Peçzkowska; Clara Fuentes Gomez; Thomas Strassburg; Christian Pawlu; Mary Buchta; Maren Salzmann; Michael M Hoffmann; Ansgar Berlis; Ingo Brink; Markus Cybulla; Mihaela Muresan; Martin A Walter; Flavio Forrer; Matti Välimäki; Andrzej Kawecki; Zbigniew Szutkowski; Jörg Schipper; Martin K Walz; Pascal Pigny; Catherine Bauters; Joan E Willet-Brozick; Bora E Baysal; Andrzej Januszewicz; Charis Eng; Giuseppe Opocher; Hartmut P H Neumann
Journal:  JAMA       Date:  2005-10-26       Impact factor: 56.272

5.  Genetic testing in pheochromocytoma or functional paraganglioma.

Authors:  Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac-de Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

6.  von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

Authors:  M A Hoffman; M Ohh; H Yang; J M Klco; M Ivan; W G Kaelin
Journal:  Hum Mol Genet       Date:  2001-05-01       Impact factor: 6.150

7.  A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas.

Authors:  Margarete Maier-Woelfle; Michael Brändle; Paul Komminoth; Parvin Saremaslani; Sonja Schmid; Tamara Locher; Philipp U Heitz; Ina Krull; Renato L Galeazzi; Christoph Schmid; Aurel Perren
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

8.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

9.  Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene.

Authors:  Abbie L Young; Bora E Baysal; Arjun Deb; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

10.  Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.

Authors:  Jean-Pierre Bayley; Ivonne van Minderhout; Marjan M Weiss; Jeroen C Jansen; Peter H N Oomen; Fred H Menko; Barbara Pasini; Barbara Ferrando; Nora Wong; Lesley C Alpert; Rosie Williams; Edward Blair; Peter Devilee; Peter E M Taschner
Journal:  BMC Med Genet       Date:  2006-01-11       Impact factor: 2.103

View more
  2 in total

1.  Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.

Authors:  Peter M Sadow; Kandelaria M Rumilla; Lori A Erickson; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Recurrent paraganglioma of Meckel's cave: Case report and a review of anatomic origin of paragangliomas.

Authors:  Anna Prajsnar; Naci Balak; Gerhard F Walter; Alexandru C Stan; Wolfgang Deinsberger; Leyla Tapul; Cicek Bayindir
Journal:  Surg Neurol Int       Date:  2011-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.